ITM: Innovative Transfusion Medicine
ITM’s Chief Executive Officer (CEO) Robert Mckie has over 31 years of successes in various roles in the diagnostic blood products industry, ranging from sales to CEO of several companies. Notably, he served as a Director of Sales at Boston BioMedica, Inc. from 1992-1994. In 1994, he co-founded BioClinical Partners, Inc. and served as Chief Operating Officer until 1999 when the business was acquired by IMPATH Inc. He continued as VP of Operations for IMPATH Predictive Oncology™ division helping develop the GeneBank™ initiative and the IMPATH Clinical Trials Network™ (ICTN).
At Medical Research Networx, Bob has provided consultation services for hospitals and life science companies. He also successfully developed clinical services worldwide, providing protocol-directed and IEC-approved clinical studies that continue to deliver thousands of biospecimens to oncology and infectious disease researchers annually.
Rest assured in each location, we have a fantastic team ready to welcome our community blood donors with open arms. Not only will you save lives with your donation, but you will also get a sense of togetherness, a sense of the very impact you make choosing ITM as your community blood bank.
ITM is an ever-evolving community appreciative blood bank offering a wide range of services from health physicals and screenings to providing our COVID Antibody Tracking services every time you donate with us!
We aim to redefine the true meaning of what being a blood donor is by changing our approach from a standard or general visit to a more personalized donation catered to keeping you well informed.